TGF-β signaling in tumor suppression and cancer progression
Top Cited Papers
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Nature Genetics
- Vol. 29 (2) , 117-129
- https://doi.org/10.1038/ng1001-117
Abstract
Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide continuously, making them prime targets for genetic and epigenetic changes that lead to cell transformation and tumorigenesis. The consequent changes in cell behavior and responsiveness result not only from genetic alterations such as activation of oncogenes or inactivation of tumor suppressor genes, but also from altered production of, or responsiveness to, stimulatory or inhibitory growth and differentiation factors. Among these, transforming growth factor β (TGF-β) and its signaling effectors act as key determinants of carcinoma cell behavior. The autocrine and paracrine effects of TGF-β on tumor cells and the tumor micro-environment exert both positive and negative influences on cancer development. Accordingly, the TGF-β signaling pathway has been considered as both a tumor suppressor pathway and a promoter of tumor progression and invasion. Here we evaluate the role of TGF-β in tumor development and attempt to reconcile the positive and negative effects of TGF-β in carcinogenesis.Keywords
This publication has 268 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Overexpression of transforming growth factor ?-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cellsInternational Journal of Cancer, 1999
- TGFβ signaling is necessary for carcinoma cell invasiveness and metastasisCurrent Biology, 1998
- Induction of Inhibitory Smad6 and Smad7 mRNA by TGF-β Family MembersBiochemical and Biophysical Research Communications, 1998
- A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF‐β signalsFEBS Letters, 1998
- The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunityImmunology Today, 1997
- Synthesis of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in human hepatoma cells (HepG2) Up‐regulation by interleukin‐6 and transforming growth factor β1FEBS Letters, 1992
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor βDevelopmental Biology, 1989